Nazione: Svizzera
Lingua: francese
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
lapatinibum
GlaxoSmithKline AG
L01EH01
lapatinibum
Comprimés pelliculés
lapatinibum 250 mg ut lapatinibi ditosilas monohydricus 405 mg, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto, natrium 2.82 mg.
A
Synthetika
Cytostatique
zugelassen
2015-12-03